Francois Vigneault

Francois Vigneault

Company: Shape Therapeutics

Job title: Co-Founder, President & CEO


Application of ADAR in Development of Rare Disease Therapeutics 9:10 am

• Why we are using RNA Editing over contemporary genome engineering technologies (CRISPR, TALENs and Zinc Fingers) • Why is ADAR our focus and how does it solve the problems that CRISPR presented? • Exploring ShapeTX’s technology core platform “RNAfix”Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.